Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase–ProducingEscherichia coliInfections in Patients with Pyelonephritis, United States1
Authors:
- David A. TalanDTDavid A. Talan
- Sukhjit S. TakharSTSukhjit S. Takhar
- Anusha KrishnadasanAKAnusha Krishnadasan
- Fredrick M. AbrahamianFAFredrick M. Abrahamian
- William R. MowerWMWilliam R. Mower
- Gregory J. MoranGMGregory J. Moran
- EMERGEncy ID Net Study GroupEGEMERGEncy ID Net Study Group
Open Access
- 1 September 2016
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 22 (9) , 1594-1603
Abstract
For 2013-2014, we prospectively identified US adults with flank pain, temperature >38.0°C, and a diagnosis of acute pyelonephritis, confirmed by culture. Cultures from 453 (86.9%) of 521 patients grew Escherichia coli. Among E. coli isolates from 272 patients with uncomplicated pyelonephritis and 181 with complicated pyelonephritis, prevalence of fluoroquinolone resistance across study sites was 6.3% (range by site 0.0%-23.1%) and 19.9% (0.0%-50.0%), respectively; prevalence of extended-spectrum β-lactamase (ESBL) production was 2.6% (0.0%-8.3%) and 12.2% (0.0%-17.2%), respectively. Ten (34.5%) of 29 patients with ESBL infection reported no exposure to antimicrobial drugs, healthcare, or travel. Of the 29 patients with ESBL infection and 53 with fluoroquinolone-resistant infection, 22 (75.9%) and 24 (45.3%), respectively, were initially treated with in vitro inactive antimicrobial drugs. Prevalence of fluoroquinolone resistance exceeds treatment guideline thresholds for alternative antimicrobial drug strategies, and community-acquired ESBL-producing E. coli infection has emerged in some US communities.Keywords
This publication has 23 references indexed in Scilit:
- Impact of Extended-Spectrum Beta-Lactamase on Acute Pyelonephritis Treated with Empirical CeftriaxoneMicrobial Drug Resistance, 2014
- Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency DepartmentEmergency Medicine International, 2013
- Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical CenterAntimicrobial Agents and Chemotherapy, 2013
- Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae –A Case–Control Study in a Low Prevalence CountryPLOS ONE, 2013
- Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United StatesClinical Infectious Diseases, 2012
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)International Journal of Antimicrobial Agents, 2006
- Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in WomenJAMA, 2000
- EMERGEncy ID NET: An Emergency Department–Based Emerging Infections Sentinel NetworkAnnals of Emergency Medicine, 1998